WMH and AD: is CAA the missing piece? Potential consequences at the anti‐amyloid era
Andreas Charidimou, Department of Neurology, Boston University School of Medicine, Boston, MA, USA · 2025
Read WMH and AD: is CAA the missing piece? Potential consequences at the anti‐amyloid era by Andreas Charidimou, Department of Neurology, Boston University School of Medicine, Boston, MA, USA (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11715163.txt.
Description
Andreas Charidimou argues, in a 2025 presentation abstract, that amyloid in brain vessel walls is the missing piece linking white matter spots to Alzheimer's disease. This vessel disease, cerebral amyloid angiopathy, is very common in Alzheimer's patients and raises the risk of anti-amyloid treatments. Certain white matter patterns on scans now count as supporting signs of it in the Boston criteria, including a multispot pattern near the cortex. The talk covers the core scan markers and what they mean for treatment side effects like swelling and bleeding.
Catalog record
| CREATOR | Andreas Charidimou, Department of Neurology, Boston University School of Medicine, Boston, MA, USA |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 946 bytes |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |